|
|
|
Suzhou Lixinpharmaceutical Co., Ltd.
|
|
| |
|
|
|
|

|

|
Click to enlarge image
|
Model Number |
Enterprise standard |
|
Donepezil Hydrochloride
|
|
[ Product introduction ]
|
It is the second generation drug for treating senile dementia. Compared with same kind of drugs, it has low rate of adverse reaction. Donepezil Hydrochloride is the only drug that can reach the standard of FDA, and the only drug on market that is approved by FDA and MCA. |
|
[ Structural formula ]
|
 |
|
[ C A S ]
|
120011-70-3 |
|
[ Chemical name ]
|
1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine hydrochloride |
|
[ Molecular formula ]
|
C24H29NO3·HCl |
|
[ Molecular weight ]
|
415.96 |
|
[ Property ]
|
White crystal or crystalline powder, melting point:217 ~ 218 °C.
|
|
[ Packing specification ]
|
1- - 5Kg / tin |
|
[ Storage ]
|
Sealed and stored at room temperature.
|
|
[ Executive standard ]
|
Enterprise standard
|
|
[ Main index ]
|
Appearance:White or white-like powder Melting point:233~ 235 °C,231~ 235 °C Loss on drying: ≤0.2% Relevant impurities( HPLC ):≤0.2% ≤0.5% Content: ≥99%,≥99.5%.
|
|
|
Supply ability |
500kg per year |
|
|
| |
|
|
|